Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06934746

Evaluation of Screen Time and Digital Media on ADHD

1. Assess how different types of digital media influence inattention, impulsivity, and hyperactivity in children with ADHD. 2. Analyze the role of screen time duration, content type, parental supervision, and socioeconomic status in ADHD symptom severity.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

3 year–12 year

Sex eligibility

All sexes

Study type

Observational

About this study

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders in children, characterized by persistent patterns of inattention, hyperactivity, and impulsivity. Studies suggest that its prevalence has risen due to improved recognition and changing diagnostic criteria. Children with ADHD experience significant challenges in school performance, including difficulty sustaining attention, frequent careless mistakes, and trouble following instructions, all of which contribute to lower academic achievement and increased need for special education support. ADHD is linked to problematic eating behaviors, as irregular meal patterns, increased consumption of unhealthy foods, and a higher risk of obesity due to impulsivity and poor self-regulation. Beyond academics and nutrition, ADHD also affects sleep quality, emotional regulation, and social interactions, leading to increased behavioral issues and conflicts with peers and family members. The widespread use of digital media further complicates these challenges, as excessive screen time has been associated with exacerbating ADHD symptoms and negatively impacting cognitive and emotional development. These findings highlight the urgent need for targeted interventions to support children with ADHD across multiple aspects of their daily lives

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed children with ADHD, confirmed by DSM-5 and Gilliam ADHD rating scale. • Parental consent for participation.

Exclusion criteria

  • Comorbid neurodevelopmental disorders (e.g., autism, intellectual disability). • Chronic medical conditions affecting cognitive or behavioral function.

Treatment and study plan

DSM-5 criteria.

Other

The DSM-5 defines three levels of ADHD severity based on symptom count and frequency: 1. Mild ADHD • Symptom Count: Just meets the diagnostic criteria (6 symptoms in children for either inattention or hyperactivity/impulsivity). • Frequency: Symptoms occur but are not excessively frequent. 2. Moderate ADHD • Symptom Count: More than the minimum required for diagnosis. • Frequency: Symptoms occur frequently (e.g., several times a week). 3. Severe ADHD • Symptom Count: Many symptoms well beyond the diagnostic threshold. • Frequency: Symptoms occur daily or multiple times per day.(National Center for Biotechnology Information, n.d.)

Primary outcomes

  1. Change in Inattention Symptoms Measured by the ADHD Rating Scale-IV

    Time frame: Baseline (Day 1) and after 6 months of follow-up

    Evaluate the change in inattention symptoms before and after exposure to different types of digital media (e.g., videos, games, educational apps) using the ADHD Rating Scale-IV completed by parents or caregivers.

  2. Change in Hyperactivity/Impulsivity Symptoms Measured by the ADHD Rating Scale-IV

    Time frame: Baseline (Day 1) and after 6 months of follow-up

    Assess the change in hyperactivity and impulsivity symptoms in children with ADHD in relation to total daily screen time, content type, and level of parental supervision, using the ADHD Rating Scale-IV.

Secondary outcomes

  1. Correlation between Socioeconomic Status and ADHD Symptom Severity

    Time frame: After 6 months of follow-up

    Analyze the association between family socioeconomic status (SES) and the severity of ADHD symptoms after 6 months of exposure to digital media, using standardized SES assessment tools and ADHD Rating Scale-IV scores.

Study contacts

Contact information is provided by the study sponsor or research team.

Emad ElDeen Mahmoud Hammad, Professor

CONTACT

[email protected]

01223559943

Janice Gamil Sadek, MD

CONTACT

[email protected]

01288823678

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Acronym: ADHD

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 18, 2025
Registry last updated
Apr 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.